Synthesis and Anticancer Activity of Rhopaladins' Analog RPDPD Against the HeLa Human Cervical Cancer Cell Line.

Chen, Feng; Wang, Hong-Mei; Kong, Ling-Qi; Chen, Qin-Hua; Ke, Li-Na; Dai, He-Liu; Zeng, Xiao-Hua

Chen, Feng; Wang, Hong-Mei; Kong, Ling-Qi; Chen, Qin-Hua; Ke, Li-Na; Dai, He-Liu; Zeng, Xiao-Hua.

Afiliação

Chen F; Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan, China.
Wang HM; Hubei Key Laboratory of Wudang Local Chinese Medicine Research, School of Pharmaceutical Sciences, Hubei University of Medicine, Shiyan, China.
Kong LQ; Hubei Key Laboratory of Wudang Local Chinese Medicine Research, School of Pharmaceutical Sciences, Hubei University of Medicine, Shiyan, China.
Chen QH; Hubei Key Laboratory of Wudang Local Chinese Medicine Research, School of Pharmaceutical Sciences, Hubei University of Medicine, Shiyan, China.
Ke LN; Shenzhen Baoan Authentic TCM Therapy Hospital, Shenzhen, China.
Dai HL; Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan, China.
Zeng XH; Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan, China.

Front Chem ; 10: 921276, 2022.

Article em En | MEDLINE | ID: mdl-35844635

Palavras-chave

2-aroyl-4-arylidene-5-oxopyrrolidine; HPV E6/E7 mRNA; TIMP3/MMP3 pathway; cytotoxicity evaluation; rhopaladins' analog; synthesis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Chem Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google